World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
92
Citations
19841
World Ranking
1015
National Ranking
550

Medicine

D-Index
92
Citations
20012
World Ranking
11469
National Ranking
5878

Overview

Cory M. Hogaboam is affiliated with the Cedars-Sinai Medical Center in the United States. Their primary field of study is Medicine, with a focus on Pulmonary and Respiratory Medicine. Additional areas of work include Molecular Biology, Immunology, Surgery, and Physiology.

The research topics extensively covered by Hogaboam include:

  • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
  • Neonatal Respiratory Health Research
  • Medical Imaging and Pathology Studies
  • Occupational and Environmental Lung Diseases
  • Congenital Diaphragmatic Hernia Studies
  • Respiratory Support and Mechanisms
  • Extracellular Vesicles in Disease

Hogaboam has contributed to numerous publications, frequently collaborating with co-authors such as Barry R. Stripp, Ana Lúcia Coelho, Changfu Yao, Milena S. Espíndola, and Peter Chen. The most common venues where their work appears are:

  • American Journal of Respiratory and Critical Care Medicine
  • bioRxiv (Cold Spring Harbor Laboratory)
  • iScience
  • JCI Insight
  • Nature Communications

Selected recent papers illustrating the scope of Hogaboam's research include:

  • Single-Cell Reconstruction of Human Basal Cell Diversity in Normal and Idiopathic Pulmonary Fibrosis Lungs, 2020, American Journal of Respiratory and Critical Care Medicine
  • Categorization of Lung Mesenchymal Cells in Development and Fibrosis, 2021, iScience
  • Increased Expression and Accumulation of GDF15 in IPF Extracellular Matrix Contribute to Fibrosis, 2022, JCI Insight
  • Differential Responses to Targeting Matrix Metalloproteinase 9 in Idiopathic Pulmonary Fibrosis, 2020, American Journal of Respiratory and Critical Care Medicine
  • Immune Mechanisms in Fibrotic Interstitial Lung Disease, 2024, Cell

Best Publications

  • Future directions in idiopathic pulmonary fibrosis research. An NHLBI workshop report.

    Timothy S. Blackwell;Andrew M. Tager;Zea Borok;Bethany B. Moore

  • Bleomycin Induces Molecular Changes Directly Relevant to Idiopathic Pulmonary Fibrosis: A Model for “Active” Disease

    Ruoqi Peng;Sriram Sridhar;Gaurav Tyagi;Jonathan E Phillips

  • Epigenetic regulation of dendritic cell–derived interleukin-12 facilitates immunosuppression after a severe innate immune response

    Haitao Wen;Yali Dou;Cory M. Hogaboam;Steven L. Kunkel

  • MMP Mediated Degradation of Type IV Collagen Alpha 1 and Alpha 3 Chains Reflects Basement Membrane Remodeling in Experimental and Clinical Fibrosis – Validation of Two Novel Biomarker Assays

    Jannie Marie Sand;Lise Skakkebæk Larsen;Cory Hogaboam;Fernando Martinez

  • The Chemokine RANTES Is a Crucial Mediator of the Progression from Acute to Chronic Colitis in the Rat

    Maureen N. Ajuebor;Cory M. Hogaboam;Steven L. Kunkel;Amanda E. I. Proudfoot

  • Epigenetic Changes in Bone Marrow Progenitor Cells Influence the Inflammatory Phenotype and Alter Wound Healing in Type 2 Diabetes

    Katherine A. Gallagher;Amrita Joshi;William F. Carson;Matthew Schaller

  • MIP‐1α[CCL3] acting on the CCR1 receptor mediates neutrophil migration in immune inflammation via sequential release of TNF‐α and LTB4

    Cleber D. L. Ramos;Claudio Canetti;Claudio Canetti;Janeusa T. Souto;Janeusa T. Souto;João S. Silva

  • Serum amyloid P therapeutically attenuates murine bleomycin-induced pulmonary fibrosis via its effects on macrophages.

    Lynne A Murray;Rogério S. Rosada;Ana Paula Duarte Moreira;Amrita D Joshi

  • Amelioration of sepsis by inhibiting sialidase-mediated disruption of the CD24-SiglecG interaction

    Guo Yun Chen;Xi Chen;Samantha King;Karen A. Cavassani

  • Prostaglandin E2 inhibits collagen expression and proliferation in patient-derived normal lung fibroblasts via E prostanoid 2 receptor and cAMP signaling

    Steven Kenneth Huang;Scott H Wettlaufer;Cory M Hogaboam;David M Aronoff

  • The Toll-like receptor 3 L412F polymorphism and disease progression in idiopathic pulmonary fibrosis.

    DN O'Dwyer;ME Armstrong;G Trujillo;G Cooke

  • Differential monocyte chemoattractant protein-1 and chemokine receptor 2 expression by murine lung fibroblasts derived from Th1- and Th2-type pulmonary granuloma models.

    Cory M. Hogaboam;Cynthia L. Bone-Larson;Scott Lipinski;Nicholas W. Lukacs

  • Novel Role of Transmembrane SCF for Mast Cell Activation and Eotaxin Production in Mast Cell-Fibroblast Interactions

    Cory Hogaboam;Steven L. Kunkel;Robert M. Strieter;Dennis D. Taub

  • Hyper-responsiveness of IPF/UIP fibroblasts: Interplay between TGFβ1, IL-13 and CCL2

    Lynne A. Murray;Rochelle L. Argentieri;Francis X. Farrell;Michelle Bracht

  • Airway hyperresponsiveness, but not airway remodeling, is attenuated during chronic pulmonary allergic responses to Aspergillus in CCR4-/- mice.

    Jane M. Schuh;Christine A. Power;Amanda E. Proudfoot;Steven L. Kunkel

  • Quercetin Enhances Ligand-induced Apoptosis in Senescent Idiopathic Pulmonary Fibrosis Fibroblasts and Reduces Lung Fibrosis In Vivo.

    Miriam S. Hohmann;David M. Habiel;Ana L. Coelho;Waldiceu A. Verri

  • Cytokine Induced Phenotypic and Epigenetic Signatures Are Key to Establishing Specific Macrophage Phenotypes

    Nicolai A. Kittan;Ronald M. Allen;Abhay Dhaliwal;Karen A. Cavassani

  • Reversal of long-term sepsis-induced immunosuppression by dendritic cells.

    Claudia F. Benjamim;Steven K. Lundy;Nicholas W. Lukacs;Cory M. Hogaboam

  • Enhanced Pulmonary Allergic Responses to Aspergillus in CCR2−/− Mice

    Kate Blease;Borna Mehrad;Theodore J. Standiford;Nicholas W. Lukacs

  • Hypermethylation of PTGER2 Confers Prostaglandin E2 Resistance in Fibrotic Fibroblasts from Humans and Mice

    Steven K. Huang;Aaron S. Fisher;Anne M. Scruggs;Eric S. White

  • Macrophages in Allergic Asthma: Fine-Tuning Their Pro- and Anti-Inflammatory Actions for Disease Resolution

    Ana Paula Moreira;Cory M. Hogaboam

  • Exaggerated hepatic injury due to acetaminophen challenge in mice lacking C-C chemokine receptor 2

    Cory M. Hogaboam;Cynthia L. Bone-Larson;Matthew L. Steinhauser;Akihiro Matsukawa

Frequent Co-Authors

Steven L. Kunkel
Steven L. Kunkel University of Michigan–Ann Arbor
Nicholas W. Lukacs
Nicholas W. Lukacs University of Michigan–Ann Arbor
Fernando J. Martinez
Fernando J. Martinez University of Massachusetts Chan Medical School
Robert M. Strieter
Robert M. Strieter University of Virginia
Stephen W. Chensue
Stephen W. Chensue University of Michigan–Ann Arbor
Kevin R. Flaherty
Kevin R. Flaherty University of Michigan–Ann Arbor
Galen B. Toews
Galen B. Toews University of Michigan–Ann Arbor
Paul W. Noble
Paul W. Noble Cedars-Sinai Medical Center
Theodore J. Standiford
Theodore J. Standiford University of Michigan–Ann Arbor
Darryl A. Knight
Darryl A. Knight University of Newcastle Australia

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a degree in Immunology opens doors to diverse career options in healthcare and research. For those interested in nursing, specialized programs such as the cheapest pmhnp programs online offer affordable pathways to become Psychiatric-Mental Health Nurse Practitioners, emphasizing care for patients with complex immunological and neurological conditions.

Advanced practice nurses aiming to expand their expertise can explore bridge programs like the fnp to acnp bridge program online. These programs provide a streamlined transition from Family Nurse Practitioner to Acute Care Nurse Practitioner, focusing on critical patient management, often involving immune-related acute diseases.

The demand for highly trained nurse practitioners affects earning potential significantly. To understand financial prospects, reviewing data on how much do dnps make can help future graduates make informed decisions about their career paths in immunology-related healthcare fields.

For those seeking a faster route into nursing practice, accelerated nurse practitioner programs provide intensive training that combines foundational and advanced coursework, enabling quicker entry into specialized roles relevant to immunology and patient care.

Best Scientists Citing Cory M. Hogaboam

Trending Scientists